Google
×
Investor Relations. Akari Therapeutics, plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.
... AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, and Peak Bio Inc. (OTC: PKBO), a clinical ...
Find the latest Akari Therapeutics plc ADS (AKTX) annual income statements, balance sheets, financial statements, ratios, and cash flow data at Nasdaq.com.
Find annual and quearterly earnings data for Akari Therapeutics plc ADS (AKTX) including earnings per share, earnings forecasts at Nasdaq.com.
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing. BOSTON and LONDON, Jan.
Missing: relations | Show results with:relations
Akari Therapeutics, Plc - Depositary Receipt (Common Stock) (US:AKTX) has 17 institutional owners and shareholders that have filed 13D/G or 13F forms with ...
People also ask
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and ...
Missing: relations | Show results with:relations
In depth view into AKTX (Akari Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.
AKTX SEC Filings - Akari Therapeutics, Plc - Depositary Receipt (Common Stock)- Annual Report, Proxy Statement, Prospectus.
Detailed price information for Akari Therapeutics ADR (AKTX-Q) from The Globe and Mail including charting and trades.